Related references
Note: Only part of the references are listed.Prognostic relevance of clinical and biological risk factors in childhood medulloblastoma: Results of patients treated in the prospective multicenter trial HIT'91
Stefan Rutkowski et al.
CLINICAL CANCER RESEARCH (2007)
Transgenic E2F1 expression in the mouse brain induces a human-like bimodal pattern of tumors
Melissa V. Olson et al.
CANCER RESEARCH (2007)
Nodule formation and desmoplasia in medulloblastomas - Defining the nodular/desmoplastic variant and its biological behavior
Charles S. McManamy et al.
BRAIN PATHOLOGY (2007)
CGHcall: calling aberrations for array CGH tumor profiles
Mark A. van de Wiel et al.
BIOINFORMATICS (2007)
Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis
Steven C. Clifford et al.
CELL CYCLE (2006)
Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial
Amar Gajjar et al.
LANCET ONCOLOGY (2006)
Retinoblastoma family proteins as key targets of the small DNA virus oncoproteins
A. Felsani et al.
ONCOGENE (2006)
High-resolution array-based comparative genomic hybridization of medulloblastomas and supratentorial primitive neuroectodermal tumors
Martin Gerard McCabe et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
Genornics identifies medulloblastoma subgroups that are enriched for specific genetic alterations
MC Thompson et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Array CGH analysis of pediatric medulloblastomas
MR Rossi et al.
GENES CHROMOSOMES & CANCER (2006)
Mutational analysis of PDGFR-RAS/MAPK pathway activation in childhood medulloblastoma
RJ Gilbertson et al.
EUROPEAN JOURNAL OF CANCER (2006)
OTX1 and OTX2 expression correlates with the clinicopathologic classification of medulloblastomas
T de Haas et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
β-catenin status predicts a favorable outcome in childhood medulloblastoma:: The United Kingdom Children's Cancer Study Group Brain Tumour Committee
DW Ellison et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Identification of a novel homozygous deletion region at 6q23.1 in medulloblastomas using high-resolution array comparative genomic hybridization analysis
ABY Hui et al.
CLINICAL CANCER RESEARCH (2005)
PAGE: Parametric analysis of gene set enrichment
SY Kim et al.
BMC BIOINFORMATICS (2005)
Treatment of early childhood medulloblastoma by postoperative chemotherapy alone
S Rutkowski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Human and mouse oligonucleotide-based array CGH
P van den IJssel et al.
NUCLEIC ACIDS RESEARCH (2005)
Combined histopathological and molecular cytogenetic stratification of medulloblastoma patients
JM Lamont et al.
CLINICAL CANCER RESEARCH (2004)
Molecular pathogenesis of childhood brain tumors
T Pietsch et al.
JOURNAL OF NEURO-ONCOLOGY (2004)
Comparison of medulloblastoma and normal neural transcriptomes identifies a restricted set of activated genes
K Boon et al.
ONCOGENE (2003)
PDGFRB is overexpressed in metastatic medulloblastoma
RJ Gilbertson et al.
NATURE GENETICS (2003)
Role of Wnt pathway in medulloblastoma oncogenesis
N Yokota et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Mutations in SUFU predispose to medulloblastoma
MD Taylor et al.
NATURE GENETICS (2002)
Prediction of central nervous system embryonal tumour outcome based on gene expression
SL Pomeroy et al.
NATURE (2002)
Histopathologic grading of medulloblastomas - A pediatric oncology group study
CG Eberhart et al.
CANCER (2002)
Genetic alterations in childhood medulloblastoma analyzed by comparative genomic hybridization
EMC Michiels et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2002)
Trilateral retinoblastoma variant indicative of the relevance of the retinoblastoma tumor-suppressor pathway to medulloblastomas in humans - Case report
WJ Elias et al.
JOURNAL OF NEUROSURGERY (2001)
Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease
TJ MacDonald et al.
NATURE GENETICS (2001)
Clinical and molecular stratification of disease risk in medulloblastoma
R Gilbertson et al.
BRITISH JOURNAL OF CANCER (2001)
Somatic mutations of WNT/wingless signaling pathway components in primitive neuroectodermal tumors
A Koch et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization, and spectral karyotyping
J Bayani et al.
JOURNAL OF NEUROSURGERY (2000)
Neurotrophin receptor TrkC predicts good clinical outcome in medulloblastoma and other primitive neuroectodermal brain tumors
MA Grotzer et al.
KLINISCHE PADIATRIE (2000)
Nuclear localization and mutation of β-catenin in medulloblastomas
CG Eberhart et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2000)
APC mutations in sporadic medulloblastomas
HT Huang et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
